- /
- Supported exchanges
- / MX
- / EW.MX
Edwards Lifesciences Corporation (EW MX) stock market data APIs
Edwards Lifesciences Corporation Financial Data Overview
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Edwards Lifesciences Corporation data using free add-ons & libraries
Get Edwards Lifesciences Corporation Fundamental Data
Edwards Lifesciences Corporation Fundamental data includes:
- Net Revenue: 5 685 M
- EBITDA: 1 741 M
- Earnings Per Share: 44
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Edwards Lifesciences Corporation Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2026-11-04
- EPS/Forecast: 0.74
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Edwards Lifesciences Corporation News
New
Edwards Lifesciences' Progress Data Unlikely to Expand TAVR Market, RBC Says
Edwards Lifesciences' (EW) Progress trial is unlikely to meaningfully expand the market for transcat Keep reading this article with Yahoo Finance Plus Silver Upgrade to Silver Silver Premium news ...
Edwards Lifesciences Says TAVR Superior to Surveillance in Moderate Aortic Stenosis Trial
Edwards Lifesciences (EW) said Monday its Progress trial showed that proactive transcatheter aortic Keep reading this article with Yahoo Finance Plus Silver Upgrade to Silver Silver Premium news F...
CLASP II TR Trial Demonstrates Superior Clinical, Quality-of-Life Benefits With Edwards PASCAL System
SAN DIEGO, November 02, 2026--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced that the PASCAL system for tricuspid repair demonstrated superiority compared to medical ther...
Progress Trial Demonstrates Edwards TAVR Is Superior to Clinical Surveillance for Moderate AS Patients With At-Risk Features
TAVR delivered more than 30% reduction in the composite endpoint of death or heart failure event as compared with clinical surveillance; results published in NEJM TAVR demonstrated unparalleled safety...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.